The interference efficiency of the HDAC4 siRNAs was determined by RNAiMax (Invitrogen) according to the manufacturer’s protocol in rat C6 glioma cells, which were obtained from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai). Here, HDAC4 is linked to central nervous system cancer.